PI3K p110α Blockade Enhances Anti-Tumor Efficacy of Abemaciclib in Human Colorectal Cancer Cells

SIMPLE SUMMARY: Colorectal cancer (CRC) is the third most common cancer and the second highest cause of cancer related mortality worldwide. Especially, the survival of advanced CRC patients who were failed to achieve durable remission after the anti-angiogenic and anti-epithelial growth factor recep...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyun Jung, Kim, Kui-Jin, Sung, Ji Hea, Nam, Milang, Suh, Koung Jin, Kim, Ji-Won, Kim, Se Hyun, Kim, Jin Won, Kim, Yu Jung, Lee, Keun-Wook, Lee, Jong Seok, Kim, Jee Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564416/
https://www.ncbi.nlm.nih.gov/pubmed/32899250
http://dx.doi.org/10.3390/cancers12092500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564416/
https://www.ncbi.nlm.nih.gov/pubmed/32899250
http://dx.doi.org/10.3390/cancers12092500

Ejemplares similares